PubRank

N Moatti

Author PubWeight™ 63.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cardiac troponin I: its contribution to the diagnosis of perioperative myocardial infarction and various complications of cardiac surgery. Crit Care Med 2001 2.26
2 Imipenem/vancomycin for Rhodococcus equi pulmonary infection in HIV-positive patient. Lancet 1991 1.66
3 Monoclonal and oligoclonal gammopathies in heart-transplant recipients. Clin Chem 1991 1.54
4 Simultaneous determination of serum neopterin and C-reactive protein as markers of infection in heart-transplant recipients. Clin Chem 1989 1.52
5 HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum. Arterioscler Thromb Vasc Biol 1997 1.51
6 A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer. Arterioscler Thromb 1994 1.19
7 Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: Chronic Haemodialysis And New Cardiac Markers Evaluation (CHANCE) study. Nephrol Dial Transplant 2001 1.08
8 Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol 1998 1.07
9 Study of minimal inhibitory concentration of antibiotics on bacteria cultivated in vitro in space (Cytos 2 experiment). Aviat Space Environ Med 1985 1.07
10 Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apoA-I transgenic rats. J Lipid Res 1996 1.04
11 [In vitro activity of twenty antibiotics against Rhodococcus equi]. Pathol Biol (Paris) 1991 1.01
12 Antibiotic activity in space. Drugs Exp Clin Res 1986 0.99
13 Oxidative modifications of low-density lipoproteins (LDL) by the human endothelial cell line EA.hy 926. Experientia 1996 0.92
14 Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI. J Clin Invest 1995 0.90
15 Coronary calcification and its relation to extracoronary atherosclerosis in asymptomatic hypercholesterolemic men. The PCV METRA Group. Circulation 1992 0.89
16 Human ApoA-IV overexpression in transgenic mice induces cAMP-stimulated cholesterol efflux from J774 macrophages to whole serum. Arterioscler Thromb Vasc Biol 2000 0.88
17 Analysis of the relationship between triglyceridemia and HDL-phospholipid concentrations: consequences on the efflux capacity of serum in the Fu5AH system. Atherosclerosis 2001 0.87
18 Behavior of bacteria and antibiotics under space conditions. Aviat Space Environ Med 1994 0.86
19 Growth and division of Escherichia coli under microgravity conditions. Res Microbiol 1994 0.86
20 Preliminary results of the "Antibio" experiment. Naturwissenschaften 1986 0.86
21 A new DNA polymorphism in the 5' untranslated region of the human SREBP-1a is related to development of atherosclerosis in high cardiovascular risk population. Atherosclerosis 2001 0.85
22 A cytotoxic electronegative LDL subfraction is present in human plasma. Arterioscler Thromb Vasc Biol 1996 0.85
23 Amino acid transport systems in the human hepatoma cell line Hep G2. Biochem Biophys Res Commun 1992 0.84
24 A method to screen for the antioxidant effect of compounds on low-density lipoprotein (LDL): illustration with flavonoids. J Pharmacol Toxicol Methods 1993 0.84
25 Lipid peroxidation abnormalities in hemodialyzed patients. Nephron 1993 0.83
26 Abnormalities of lipid metabolism and arterial rigidity in young subjects with borderline hypertension. Clin Invest Med 1994 0.82
27 Influence of HDL subfractions on erythrocyte aggregation in hypercholesterolemic men. PCVMETRA Group. Arterioscler Thromb 1994 0.82
28 Preliminary results of Cytos 2 experiment. Acta Astronaut 1985 0.82
29 Defective galactose oxidation in a patient with glycogen storage disease and Fanconi syndrome. Pediatr Res 1983 0.82
30 Homocysteine decreases endothelin-1 production by cultured human endothelial cells. Eur J Biochem 1999 0.81
31 Fractionation of charge-modified low density lipoproteins by fast protein liquid chromatography. J Lipid Res 1991 0.81
32 Biochemical diagnosis of hepatic glycogen storage diseases: 20 years French experience. Clin Biochem 1991 0.81
33 Influence of uremia on polymorphonuclear leukocytes oxidative metabolism in end-stage renal disease and dialyzed patients. Nephron 1991 0.81
34 [Hepatic glycogenoses. Introduction]. Ann Gastroenterol Hepatol (Paris) 1988 0.81
35 [Biological and physiopathological aspects of hepatic glycogenoses]. Ann Gastroenterol Hepatol (Paris) 1988 0.80
36 Endothelin and cardiovascular remodelling in end-stage renal disease. Nephrol Dial Transplant 1998 0.80
37 Association between plasma homocysteine concentrations and cardiac hypertrophy in end-stage renal disease. J Nephrol 1999 0.80
38 Charge heterogeneity of LDL in asymptomatic hypercholesterolemic men is related to lipid parameters and variations in the ApoB and CIII genes. Arterioscler Thromb Vasc Biol 1998 0.79
39 [Effect of cycloleucine on renal uptake of dibasic amino acids and cystine]. Biomedicine 1976 0.79
40 Structural changes of high-density-lipoprotein apolipoproteins following incubation with human polymorphonuclear cells. Eur J Biochem 1994 0.79
41 Transport of L-histidine by human diploid fibroblasts in culture. In Vitro 1983 0.79
42 Use of platelets, mononuclear and polymorphonuclear cells in the diagnosis of glycogen storage disease type VI. J Inherit Metab Dis 1988 0.79
43 High-density lipoprotein 3 physicochemical modifications induced by interaction with human polymorphonuclear leucocytes affect their ability to remove cholesterol from cells. Biochem J 1996 0.79
44 [Lipoprotein anomalies in HIV infections]. Ann Med Interne (Paris) 1996 0.78
45 Abnormal lipoprotein pattern in patients with Alagille syndrome depends on Icterus severity. Gastroenterology 1996 0.78
46 Characteristics of ten charge-differing subfractions isolated from human native low-density lipoproteins (LDL). No evidence of peroxidative modifications. Biochim Biophys Acta 1995 0.78
47 [Genetic variation in the apolipoprotein B gene]. Ann Genet 1995 0.78
48 [Modification of aminoaciduria in the rat after administration of cycloleucine: comparison with human cystinuria]. Clin Chim Acta 1971 0.78
49 Transport of L-alanine in cultured human fibroblasts: evidence for two kinetically distinguishable systems. J Cell Physiol 1981 0.78
50 Homocysteine-induced decrease in endothelin-1 production is initiated at the extracellular level and involves oxidative products. Eur J Biochem 2001 0.78
51 Respective effects of glucose and glutamine on the glutamine synthetase activity of human skin fibroblasts. Mol Cell Biochem 1991 0.78
52 Effect of cycloleucine on amino acid accumulation by human diploid fibroblasts. Clin Chim Acta 1978 0.78
53 Monitoring of heart allograft rejection by simultaneous measurement of serum beta 2-microglobulin and urinary neopterin. Ann Biol Clin (Paris) 1989 0.78
54 Comparative study of extracellular amino acids in culture of human liver and fibroblastic cells. In Vitro 1976 0.77
55 Enhanced modifications of low-density lipoproteins (LDL) by endothelial cells from smokers: a possible mechanism of smoking-related atherosclerosis. Cardiovasc Res 1996 0.77
56 Pre-operative colonic preparation using kanamycin and metronidazole: qualitative and quantitative effects on the bacterial flora of the intestine. J Antimicrob Chemother 1980 0.77
57 Erythrocyte, but not plasma, vitamin E concentration is associated with carotid intima-media thickening in asymptomatic men at risk for cardiovascular disease. Atherosclerosis 2001 0.77
58 Inhibition of lecithin cholesterol acyltransferase by phosphatidylcholine hydroperoxides. FEBS Lett 1999 0.77
59 Reactivity of lecithin-cholesterol acyl transferase (LCAT) towards glycated high-density lipoproteins (HDL). Clin Chim Acta 1995 0.77
60 L-proline uptake in human fibroblasts: evidence for a high-affinity system in addition to system A. Biochem Biophys Res Commun 1987 0.77
61 IL-1 beta, a strong mediator for glucose uptake by rheumatoid and non-rheumatoid cultured human synoviocytes. FEBS Lett 1992 0.77
62 Interleukin-1 beta and interleukin-6 stimulate 2-methylaminoisobutyric acid uptake in HepG2 cells. Int J Biochem Cell Biol 1997 0.77
63 [Biology of the endothelial cell and atherogenesis]. Ann Biol Clin (Paris) 1995 0.77
64 Fractional efflux and net change in cellular cholesterol content mediated by sera from mice expressing both human apolipoprotein AI and human lecithin:cholesterol acyltransferase genes. Atherosclerosis 1999 0.77
65 Erythrocyte antioxidant status in asymptomatic hypercholesterolemic men. Atherosclerosis 1998 0.77
66 Human kidney prolidase--purification, preincubation properties and immunological reactivity. Int J Biochem 1994 0.77
67 [Modified LDL and atherosclerosis. Nature of modifications. Physicochemical and biological properties]. Ann Biol Clin (Paris) 1992 0.77
68 Opposite effects of plasma homocysteine and the methylenetetrahydrofolate reductase C677T mutation on carotid artery geometry in asymptomatic adults. Arterioscler Thromb Vasc Biol 1998 0.77
69 Evidence that cycloleucine affects the high-affinity systems of amino acid uptake in cultured human fibroblasts. Biochem J 1984 0.76
70 [Membrane phospholipid peroxidation in renal insufficiency and chronic hemodialysis]. Nephrologie 1991 0.76
71 Interleukin-1 beta-induced changes in the kinetic constants of L-proline uptake in human skin fibroblasts. Biochem J 1991 0.76
72 High-density lipoprotein subfractions as markers of early atherosclerosis. PCVMETRA Group. Prévention Cardio-Vasculaire en Medecene du Travail. Am J Cardiol 1995 0.76
73 Evaluation of the sialic acid content of LDL as a marker of coronary calcification and extracoronary atherosclerosis in asymptomatic hypercholesterolemic subjects. PCVMETRA Group. Arterioscler Thromb Vasc Biol 1995 0.76
74 Glutamine dependency of human skin fibroblasts: modulation by hexoses. Exp Cell Res 1989 0.76
75 Blood lipids and rheological modifications in glycogen storage disease. Clin Biochem 1996 0.75
76 Estimated creatinine clearance by the formula of Gault and Cockcroft in renal transplantation. Nephron 1989 0.75
77 [Genetic heterogeneity and the diagnosis of hepatic glycogenoses]. C R Seances Soc Biol Fil 1984 0.75
78 D-glucose uptake in human liver cell cultures. In Vitro 1981 0.75
79 Asymptomatic hyperamylasemia after cyclosporine therapy in patients with renal transplants. Transplant Proc 1988 0.75
80 Oxidative modification of high-density lipoprotein 3 induced by human polymorphonuclear neutrophils. Protective effect of pentoxifylline. Eur J Biochem 1999 0.75
81 Study of some enzymatic activities in human liver cell cultures. Biomedicine 1979 0.75
82 [Value of transgenic mouse as model for the study of human lipoprotein metabolism]. Ann Biol Clin (Paris) 1995 0.75
83 [Isolation and identification of a new urinary oxydative metabolite of homocystine]. Clin Chim Acta 1971 0.75
84 Effect of ethanol on prolidase I and prolinase activity in the human hepatoma cell line Hep G2. Clin Chim Acta 1993 0.75
85 [Vitamin E: metabolism and role in atherosclerosis]. Ann Biol Clin (Paris) 1994 0.75
86 Oxidative modification of low-density lipoprotein by the human hepatoma cell line HepG2. Free Radic Res 1996 0.75
87 [Clinical and bacteriological appreciation of antibioprophylaxy in colorectal surgery]. Ann Chir 1982 0.75
88 Plasma insulin and ankle on brachial systolic blood pressure ratio in overweight men with hypertension. J Hypertens Suppl 1998 0.75
89 Cholesterol efflux from Fu5AH cells to the serum of patients with Alagille syndrome. Importance of the hdl-phospholipids/free cholesterol ratio and of the hdl size distribution. J Lipid Res 1999 0.75
90 Type Ib glycogen storage disease: an in vivo and in vitro study of two cases. J Inherit Metab Dis 1984 0.75
91 Amylase, isoamylase, and lipase activities in cyclosporine-treated rats. Clin Chem 1988 0.75
92 [Hypertension has no effect on coronary calcifications in asymptomatic patients with hypercholesterolemia]. Arch Mal Coeur Vaiss 1992 0.75
93 [Fructose 1,6-diphosphatase deficiency in 2 sisters]. Arch Fr Pediatr 1975 0.75
94 Usefulness of the kappa/lambda ratio for detecting a new monoclonal component in a patient with a monoclonal gammopathy. Clin Chim Acta 1994 0.75
95 A rare case of IgD gammopathy associated with free light-chain cryoglobulinemia and a gelling Bence Jones protein. Clin Chim Acta 1993 0.75
96 IgG subclass typing by immunofixation. Clin Chim Acta 1997 0.75
97 [The skin bank: its requirements, its future]. Ann Chir Plast Esthet 1988 0.75
98 Effects of serum-free culture media on human liver and fibroblastic cells. Biomedicine 1977 0.75
99 Elevated high density lipoprotein concentrations in heart transplant recipients are related to impaired plasma cholesteryl ester transfer and hepatic lipase activity. Atherosclerosis 1993 0.75
100 Methemalbumin interference in various biochemical assays of plasma. Clin Chem 1988 0.75
101 Critical study of the growth hormone response to dynamic tests and the insulin growth factor assay in acromegaly after microsurgery. Clin Endocrinol (Oxf) 1983 0.75
102 Serum prolactin as a rejection marker in heart transplantation. Clin Chem 1989 0.75
103 [Enzymatic determination of blood D-beta-hydroxybutyrate and acetoacetate during prolonged fasting tests in the child]. Ann Biol Clin (Paris) 1981 0.75
104 The Philadelphia variant of galactokinase in human erythrocytes: physicochemical and catalytic properties. Clin Chim Acta 1988 0.75
105 [Hereditary abnormalities of galactose metabolism: diagnosis and biochemical supervision (author's transl)]. Ann Biol Clin (Paris) 1979 0.75
106 [Amino acid transfer systems and their importance in pathology. II. Specific abnormalities in renal and intestinal amino acid transfer]. Ann Biol Clin (Paris) 1973 0.75
107 Plasma insulin, plasminogen activator inhibitor, and ankle-brachial systolic blood pressure ratio in overweight hypertensive subjects. J Hum Hypertens 1999 0.75
108 Glycine transport by cultured skin fibroblasts from a patient with isolated hyperglycinuria. J Inherit Metab Dis 1980 0.75
109 A study of fibrinogen and fibrinolysis in 10 adults with nephrotic syndrome. Thromb Haemost 1988 0.75
110 [Comparative theoretical activity of antibiotics on the main gram-negative bacilli]. Pathol Biol (Paris) 1969 0.75
111 [Evaluation of 2 bacterial filters connected to the respirator for the prevention of nosocomial pulmonary infection]. Agressologie 1990 0.75
112 Decreased erythrocyte deformability in glycogen storage disease. Thromb Res 1996 0.75
113 A relationship between aortic stiffness and serum HDL3 cholesterol concentrations in hypercholesterolaemic, symptom-free men. The PCVMETRA Group (Groupe de Prévention Cardiovasculaire en Médecine du Travail). J Cardiovasc Risk 1994 0.75
114 Only prolidase I activity is present in human plasma. Int J Biochem 1992 0.75
115 Separation of two erythrocyte prolidase isoforms by fast protein liquid chromatography; application to prolidase deficiency. J Chromatogr 1989 0.75
116 [Charge heterogeneity of low density lipoproteins]. Ann Biol Clin (Paris) 1996 0.75
117 [Systems of amino acid transport and their importance in pathology. I. Mode of amino acid transport in kidney and intestines]. Ann Biol Clin (Paris) 1973 0.75
118 Serum lipid abnormalities in heart transplant recipients: predominance of HDL2-like particles in the HDL pattern. Atherosclerosis 1990 0.75
119 Liver glycogenosis caused by a defective phosphorylase system: hemolysate analysis. Pediatrics 1981 0.75
120 Plasma and erythrocyte vitamin E content in asymptomatic hypercholesterolemic subjects. Clin Chem 1997 0.75
121 Influence of the environment in space on the biochemical characteristics of human low density lipoproteins. Free Radic Res 1996 0.75
122 Effect of captopril and other inhibitors of angiotensin-converting enzyme on plasma prolidase activity. Clin Chem 1988 0.75
123 [Human lung tissue and serum concentrations of cefradin (author's transl)]. Pathol Biol (Paris) 1978 0.75
124 Septic arthritis of the knee due to Neisseria mucosa. Clin Rheumatol 1985 0.75
125 [Regulation of glycogen metabolism in the liver and hepatic glycogenosis due to phosphorylase system deficiency]. C R Seances Soc Biol Fil 1979 0.75
126 Study of vitamin E net mass transfer between alpha-tocopherol-enriched HDL and erythrocytes: application to asymptomatic hypercholesterolemic men. Free Radic Biol Med 2000 0.75
127 The Philadelphia variant of galactokinase: impaired [1-14C]galactose oxidation by intact erythrocytes. Clin Chim Acta 1988 0.75
128 ESA's Biopan 1--"Vitamin" experiment preliminary results. Acta Astronaut 1998 0.75
129 Susceptibility to copper oxidation of neuraminidase-treated LDL. Clin Chim Acta 1995 0.75
130 [The cardiac pacemaker and melitococcus]. Nouv Presse Med 1977 0.75